Madrigal Pharmaceuticals Inc
LSE:0JXI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Madrigal Pharmaceuticals Inc
LSE:0JXI
|
US |
|
N
|
NTT Data Group Corp
DUS:NT5
|
JP |
|
N
|
Naturally Splendid Enterprises Ltd
F:50N
|
CA |
|
C
|
Coinbase Global Inc
BCBA:COIN
|
US |
|
B
|
Bpost SA
F:13B
|
BE |
|
B
|
Boston Scientific Corp
SWB:BSX
|
US |
|
T
|
Telefonaktiebolaget LM Ericsson
SWB:ERCG
|
SE |
|
REC Limited
BSE:532955
|
IN |
|
Sumitomo Chemical Co Ltd
OTC:SOMMF
|
JP |
|
C
|
CDK Global Inc
F:C2G
|
US |
|
Valneva SE
NASDAQ:VALN
|
FR |
|
L
|
Lonza Group AG
XMUN:LO3
|
CH |
|
V
|
Vardhman Textiles Ltd
BSE:502986
|
IN |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
FR |
|
N
|
National Grid PLC
XHAM:NNGF
|
UK |
|
U
|
United Overseas Bank Ltd
XMUN:UOB
|
SG |
|
Pacific Ridge Exploration Ltd
F:PQW
|
CA |
|
Compagnie Immobiliere de Belgique
XBRU:IMMO
|
BE |
|
C
|
Cerner Corp
XBER:CRE
|
US |
|
Regional Management Corp
NYSE:RM
|
US |
|
Globe Life Inc
NYSE:GL
|
US |
|
Bilfinger SE
OTC:BFLBF
|
DE |
|
E
|
Exelixis Inc
SWB:EX9
|
US |
|
Odfjell Drilling Ltd
OTC:ODFJF
|
UK |
Dividends
Dividend Yield
Madrigal Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Madrigal Pharmaceuticals Inc
0JXI have decreased by 0%.
Payout Ratio
Madrigal Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 0JXI is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0JXI Price
Madrigal Pharmaceuticals Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -24% |
| Market Capitalization | 11.5B USD |
| Shares Outstanding | 34 076 615 |
| Percentage of Shares Shorted |
N/A
|
